Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation
eLife · 2024
DOI: 10.7554/elife.84532 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Yifan Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, United States. Hauptthemen laut MEDLINE: YAP-Signaling Proteins, Cell Differentiation, Adaptor Proteins, Signal Transducing, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Cancer Prevention and Research Institute of Texas, CPRIT Research Training, NIDDK NIH HHS.
Abstract (Originalsprache)
The Hippo pathway plays a central role in tissue development and homeostasis. However, the function of Hippo in pancreatic endocrine development remains obscure. Here, we generated novel conditional genetically engineered mouse models to examine the roles of Hippo pathway-mediated YAP1/TAZ inhibition in the development stages of endocrine specification and differentiation. While YAP1 protein was localized to the nuclei in bipotent progenitor cells, Neurogenin 3 expressing endocrine progenitors completely lost YAP1 expression. Using genetically engineered mouse models, we found that inactivation of YAP1 requires both an intact Hippo pathway and Neurogenin 3 protein. Gene deletion of Lats1 and 2 kinases ( Lats1&2 ) in endocrine progenitor cells of developing mouse pancreas using Neurog3 Cre blocked endocrine progenitor cell differentiation and specification, resulting in reduced islets size and a disorganized pancreas at birth. Loss of Lats1&2 in Neurogenin 3 expressing cells activated YAP1/TAZ transcriptional activity and recruited macrophages to the developing pancreas. These defects were rescued by deletion of Yap1/Wwtr1 genes, suggesting that tight regulation of YAP1/TAZ by Hippo signaling is crucial for pancreatic endocrine specification. In contrast, deletion of Lats1&2 using β-cell-specific Ins1 CreER resulted in a phenotypically normal pancreas, indicating that Lats1&2 are indispensable for differentiation of endocrine progenitors but not for that of β-cells. Our results demonstrate that loss of YAP1/TAZ expression in the pancreatic endocrine compartment is not a passive consequence of endocrine specification. Rather, Hippo pathway-mediated inhibition of YAP1/TAZ in endocrine progenitors is a prerequisite for endocrine specification and differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, United States.
- Department of Obstetrics, The Second Xiangya Hospital, Central South University, Changsha, China.
- Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, United States.
- Laboratory of Receptor Biology and Gene Expression, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States.
- Department of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, United States.
ORCID-Profile: Yifan Wu, Kevin M Lopez, H Efsun Arda, Pei Wang
Förderung
- Cancer Prevention and Research Institute of Texas
- CPRIT Research Training
- NIDDK NIH HHS
- NCI NIH HHS
- Intramural NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Cancer Institute of the United States
- William and Ella Owens Medical Research Foundation, and National Cancer Institute
Zitieren
APA
Wu, Y., Qin, K., Xu, Y., Rajhans, S., Vo, T., Lopez, K. M., Liu, J., Nipper, M. H., Deng, J., Yin, X., Ramjit, L. R., Ye, Z., Luan, Y., Arda, H. E., & Wang, P. (2024). Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation. eLife. https://doi.org/10.7554/elife.84532
Vancouver
Wu Y, Qin K, Xu Y, Rajhans S, Vo T, Lopez KM, et al. Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation. eLife. 2024. doi:10.7554/elife.84532
BibTeX
@article{Wu2024,
author = {Wu, Yifan and Qin, Kunhua and Xu, Yi and Rajhans, Shreya and Vo, Truong and Lopez, Kevin M and Liu, Jun and Nipper, Michael H and Deng, Janice and Yin, Xue and Ramjit, Logan R and Ye, Zhenqing and Luan, Yu and Arda, H Efsun and Wang, Pei},
title = {Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.84532}
}
EUVIMED